Abstract
Involvement of the Notch signaling pathway in vascular development has been demonstrated by both gain- and loss-of-function mutations in humans, mice, and zebrafish. In zebrafish, Notch signaling is required for arterial identity by suppressing the venous fate in developing artery cells. In mice, the Notch4 receptor and the Delta-like 4 (Dll4) ligand are specifically expressed in arterial endothelial cells, suggesting a similar role. Here we show that the Dll4 ligand alone is required in a dosage-sensitive manner for normal arterial patterning in development. This implicates Dll4 as the specific mammalian endothelial ligand for autocrine endothelial Notch signaling, and suggests that Dll4 may be a suitable target for intervention in arterial angiogenesis.
| Original language | English |
|---|---|
| Pages (from-to) | 2474-2478 |
| Number of pages | 5 |
| Journal | Genes and Development |
| Volume | 18 |
| Issue number | 20 |
| DOIs | |
| Publication status | Published - 15 Oct 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Angiogenesis
- Arteriogenesis
- D114
- Dosage sensitivity
- Haploinsufficiency
- Notch
Fingerprint
Dive into the research topics of 'Dosage-sensitive requirement for mouse Dll4 in artery development'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver